
Oyster season opens in P.E.I. for first time since detection of MSX parasite
FREDERICTON – It's the first oyster season in Prince Edward Island since a destructive parasite was identified in the province's waters last summer, and harvesters are taking stock of the extent of the damage.
P.E.I. Fisheries Minister Zack Bell said the parasite called multinucleate sphere unknown — also known as MSX — is 'pretty much almost (on) the entire Island.'
The parasite targets both cultured and wild oysters, killing about 95 per cent of affected mollusks within two to three years of infection. MSX was found in P.E.I.'s Bedeque Bay and several other areas in July. It has been present in Nova Scotia since 2002 and in southern British Columbia since 2007.
The Canadian Food Inspection Agency says its investigation into the parasite in Bedeque Bay indicated MSX was widespread on the Island — that it was present or highly likely to be present in numerous bays and rivers across marine waters of the province.
'With the spring oyster fishery now reopening, we're beginning to see firsthand the impacts of MSX on oyster populations,' the agency said in an email. While MSX poses no risk to human health or food safety, it prevents oysters from thriving and can cause decreased rates of growth and increased oyster mortality, the agency said.
Bob MacLeod, president of the P.E.I. Shellfish Association, said his group accompanied provincial officials last week to check oysters in Bedeque Bay. The group spent nearly three hours and found about 30 oysters.
Usually, there should be thousands, he said. 'It was devastating.'
If an oyster-rich area such as Bedeque Bay is seeing a serious decline from MSX, he said, it doesn't bode well for other coastal areas that historically have had fewer mollusks. 'The big question is going to be come June and the little spots where people are fishing right now that definitely don't have the volume of oysters on them,' he said.
Winnipeg Jets Game Days
On Winnipeg Jets game days, hockey writers Mike McIntyre and Ken Wiebe send news, notes and quotes from the morning skate, as well as injury updates and lineup decisions. Arrives a few hours prior to puck drop.
The Island's oyster industry generated almost $24 million in revenue last year, with 10 million kilograms of oysters. It's the province's third-most lucrative seafood business, behind mussels at $29 million and lobster at $298 million.
Bell said that so far, the extent of the damage from MSX is a 'mixed bag.' Some oyster-rich areas such as Lennox Island, Bedeque Bay and Percival River are seeing high mollusk death tolls, while other waterways are not seeing much of a decline.
The industry is hopeful the parasite can be contained, but the sector has also been hit by 25 per tariffs imposed by the Chinese government in retaliation for Canada's duties on electric vehicles.
'It's still really early in the season to know how much of an impact it's going to have on our exports, but the hope is we'll still have a lot of oysters to produce and be able to sell on the world market,' Bell said.
This report by The Canadian Press was first published May 9, 2025.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Winnipeg Free Press
2 days ago
- Winnipeg Free Press
3 Canadian national team players among the Whitecaps stricken by illness
Three Canadian national team players were among those who fell ill following the Vancouver Whitecaps' appearance in the CONCACAF Champions Cup final last weekend in Mexico City. The Whitecaps said a 'significant number' of players and staff had a gastrointestinal illness. Three of them — Ali Ahmed, Sam Adekugbe and Jayden Nelson — were ill when they arrived at Canada's training camp in Halifax ahead of Saturday's Canadian Shield match against Ukraine, coach Jesse Marsch said Friday. 'They're better now,' Marsch said. 'They're probably not ready for 90-minute performances.' The trio practiced with the national team Friday in preparation for the match at Toronto's BMO Field. Canada also plays Ivory Coast on Tuesday as it readies for the CONCACAF Gold Cup. Marsch, who said it was his understanding that the players had food poisoning, questioned how it could happen two years in a row. Last year, Columbus Crew players fell ill while playing in the CONCACAF Champions Cup final in Mexico against Pachuca. 'If I were the Vancouver Whitecaps, if I was the Columbus Crew, if I was MLS, I would be angry. I would be absolutely angry that this had been allowed to happen,' he said. The Whitecaps were forced to cancel practice Wednesday and had a modified session for cleared players Thursday after both players and staff reported the gastrointestinal symptoms. It appeared many players had returned Friday. 'The health and well-being of our players and staff remain a top priority. Each player has been provided with an individualized program by the medical and performance staff to support their continued preparation and recovery,' the Whitecaps said in a statement. Whitecaps sporting director Axel Schuster told reporters that about half of the 75 people who returned to Canada via charter following the game reported symptoms. The Whitecaps lost 5-0 to Liga MX team Cruz Azul in the tournament's championship game Sunday night in Mexico City. Winnipeg Jets Game Days On Winnipeg Jets game days, hockey writers Mike McIntyre and Ken Wiebe send news, notes and quotes from the morning skate, as well as injury updates and lineup decisions. Arrives a few hours prior to puck drop. The Whitecaps were scheduled to play the Seattle Sounders in a Cascadia Cup rivalry match at BC Place on Sunday. Nine players were already going to be missing because of national team duty, including Ahmed, Adekugbe and Nelson. Schuster said the Whitecaps have been in contact with the league about whether the team would have enough players for the game. 'If we have enough healthy and fit players available, we want to play it, of course,' Schuster said. 'No one ever wants not to play a game if he thinks he has a group together that is ready to compete in this game.' ___ AP soccer:


Winnipeg Free Press
2 days ago
- Winnipeg Free Press
Nurse college must be able to pivot: health minister
Manitoba's health minister says the regulatory body for nursing is blocking internationally educated nurses who want to practise in the province and driving them away. 'What we're hearing from nurses — not just IENs but across the board — is that the college continues to be a barrier to nurses successfully joining the front lines and they're leaving Manitoba as a result, or not considering Manitoba as an option,' Health Minister Uzoma Asagwara said late Thursday. The health minister was defending their directive that the College of Registered Nurses of Manitoba stop requiring 'labour mobility applicants' have 450 hours of nursing experience in Canada over the past two years or 1,225 hours over the past five years. MIKAELA MACKENZIE / FREE PRESS FILES Health Minister Uzoma Asagwara: 'If Manitoba wants to be competitive in the health care staffing market, we have to be willing to adapt and evolve.' In 2022, the Progressive Conservative government directed the college to stop requiring out-of-province applicants have recent Canadian experience. The college said it then tracked a significant increase in complaints about nursing incompetence linked to labour mobility applicants, and that two patients have died as a result. It cited complaints about a lack of nursing knowledge, skill and judgment, the inability to take or interpret vital signs, perform a health assessment, safely administer medication or prioritize patient care. In December, the college reinstated the requirement for nurses to have recent Canadian experience. Asagwara ordered the college to stop, saying it was breaking internal trade laws, including the Canadian Free Trade Agreement and the New West Partnership Trade Agreement's labour mobility rules, and legislation requiring regulated professions to ensure their registration practices comply with obligations of a domestic trade agreement. College registrar Deb Elias said Wednesday the province is putting labour mobility and its support for interprovincial free trade ahead of patient safety and lives. The health minister — who is also a registered psychiatric nurse — said the college's complaints have been taken 'very seriously'and 'immediate steps' were taken to keep patients safe. The province is working with regional health authorities and employers to make sure there are pathways for internationally educated nurses to get more support or resources so they can succeed as a nurse or elsewhere on the front line, said Asagwara. The minister said the college is also rejecting qualified nurses. 'We've heard from a number of nurses in the U.S., nurse academics, federal nurses who've been trying to get licensed in Manitoba to practise in nursing stations. We've heard of cases where nurses who practised in Manitoba for over 30 years — in one case, a nurse who practised for 35 years and was short one hour in her recency was denied a licence to return to the front lines as a recently retired nurse.' Winnipeg Jets Game Days On Winnipeg Jets game days, hockey writers Mike McIntyre and Ken Wiebe send news, notes and quotes from the morning skate, as well as injury updates and lineup decisions. Arrives a few hours prior to puck drop. Asagwara said the health department's recruitment and retention office is triaging 'literally dozens of nurses who've come to us because they have not been supported by the college.' The minister said Manitoba has to be able to pivot. 'We have to be able to evolve. The college, I know, has historically been unwilling to do so. That's not the landscape of health care in Canada anymore,' Asagawara said. 'If Manitoba wants to be competitive in the health care staffing market, we have to be willing to adapt and evolve and meet the growing needs and economic realities.' Carol SandersLegislature reporter Carol Sanders is a reporter at the Free Press legislature bureau. The former general assignment reporter and copy editor joined the paper in 1997. Read more about Carol. Every piece of reporting Carol produces is reviewed by an editing team before it is posted online or published in print — part of the Free Press's tradition, since 1872, of producing reliable independent journalism. Read more about Free Press's history and mandate, and learn how our newsroom operates. Our newsroom depends on a growing audience of readers to power our journalism. If you are not a paid reader, please consider becoming a subscriber. Our newsroom depends on its audience of readers to power our journalism. Thank you for your support.


Cision Canada
2 days ago
- Cision Canada
ZEISS CLARUS 700 Receives NMPA Approval in China
"ZEISS CLARUS 700 represents a major step forward in retinal imaging," emphasizes Anuj Kalra, Head of Chronic Disease Management at ZEISS Medical Technology. "By seamlessly integrating ultra-widefield Fluorescein Angiography (FA) imaging with true-color reproduction, this system delivers unprecedented clarity for comprehensive visualization from the macular region to the extreme retinal periphery, enhancing efficiency and supporting precise decision-making within the ZEISS Retina Workflow." "Integrating ultra-widefield imaging, unsurpassed clarity, and AI-enhanced capture, the CLARUS 700 redefines fundus angiography benchmarks. It will provide unparalleled diagnostic precision for Chinese doctors and unprecedented comfort for their patients," says Maxwell Liu, Head of Sales & Services at ZEISS Medical Technology China. Ultra-widefield fluorescein angiography serves as a highly valuable examination tool for assessing nonperfused retinal areas. The ZEISS CLARUS 700 HD ultra-widefield fundus imaging camera is an advanced retinal imaging system that provides True Color, high-resolution images. It captures 133° 1 in a single image and up to 267° with multiple captures, offering detailed views of the retina. Equipped with both fluorescein angiography and live infrared imaging capabilities, the CLARUS 700 aids in diagnosing and monitoring retinal diseases 2. Furthermore, the fundus imaging camera offers innovative technology features including PrecisionFocus for quickly seeing details in the regions of interest, QuickCompare to compare pathology changes observed in past patient visits, and AutoBright so ophthalmologists can spend more time analyzing images and less time adjusting them. More information about the CLARUS ® 700 from ZEISS can be found here. 1 CLARUS 700#white-paper 2 Xiao, Y., Dan, H., Du, X. et al. Assessment of early diabetic retinopathy severity using ultra-widefield Clarus versus conventional five-field and ultra-widefield Optos fundus imaging. Sci Rep 13, 17131 (2023). Not all products, services or offers are approved or offered in every market and approved labeling and instructions may vary from one country to another. For country-specific product information, see the appropriate country website. Product specifications are subject to change in design and scope of delivery as a result of ongoing technical development. The statements of the healthcare professionals reflect only their personal opinions and experiences and do not necessarily reflect the opinion of any institution that they are affiliated with. The healthcare professionals alone are responsible for the content of their experience reported and any potential resulting infringements. Carl Zeiss Meditec AG and its affiliates to not have clinical evidence supporting the opinions and statements of the health care professionals nor accept any responsibility or liability of the healthcare professionals' content. The healthcare professionals have a contractual or other financial relationship with Carl Zeiss Meditec AG and its affiliates and have received financial support. Contact for investors Sebastian Frericks Director Investor Relations Carl Zeiss Meditec AG Phone: +49 3641 220 116 Mail: [email protected] Contact for the press Frank Smith Head of Global Communications Ophthalmology Carl Zeiss Meditec Inc. Phone: +49 3641 220 331 Mail: [email protected] Brief Profile Carl Zeiss Meditec AG (ISIN: DE0005313704), which is listed on the MDAX and TecDAX of the German stock exchange, is one of the world's leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. The Company offers complete solutions, including implants and consumables, to diagnose and treat eye diseases. The Company creates innovative visualization solutions in the field of microsurgery. With 5,730 employees worldwide, the Group generated revenue of €2,066.1m in fiscal year 2023/24 (to 30 September). The Group's head office is located in Jena, Germany, and it has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. The Center for Application and Research (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the Company's presence in these rapidly developing economies. Around 39 percent of Carl Zeiss Meditec AG's shares are in free float. Approx. 59 percent are held by Carl Zeiss AG, one of the world's leading groups in the optical and optoelectronic industries. For further information visit: